Sreenivas Rao Nandigam is a distinguished global supply chain leader and strategic executive serving as Senior Vice President and Head of Global Supply Chain at Sun Pharmaceutical Industries Ltd.—India’s largest pharmaceutical company and a leading global player in specialty and generic medicines. In this critical leadership role, Sreenivas oversees end-to-end supply chain operations for one of the world’s most complex pharmaceutical networks, ensuring the resilient movement of critical medicines, APIs, and healthcare products across international markets while sustaining operational excellence, risk management, and global distribution performance.

Mr. Nandigam is a key member of Sun Pharma’s Core Management Team (CMT), entrusted with shaping group strategy and the company’s operational frameworks on a global scale. He has been in this role since September 2017, driving transformative supply chain initiatives that enhance efficiency, responsiveness, and product availability, directly contributing to the company’s mission of delivering high-quality medicines to patients worldwide.

Before joining Sun Pharma, Sreenivas built deep domain expertise across international supply chain functions with major multinational organizations. His leadership journey includes senior regional roles at Reckitt Benckiser—where he led supply chain operations in North America and Southeast Asia—and earlier leadership positions at Unilever. These experiences endowed him with a global perspective on complex distribution networks, cross-border logistics, and strategic sourcing in highly regulated environments.

Recognized as a thought leader in supply chain excellence, he has represented Sun Pharma at leading industry forums and logistics summits, sharing insights on advanced supply chain visibility, technology integration, and risk mitigation practices that are shaping the future of global pharmaceutical supply chains.

Across his career, Mr. Nandigam has demonstrated a commitment to operational innovation, strategic alignment, and customer-centric supply chain performance, reinforcing Sun Pharma’s capability to serve patients reliably in an era defined by rapid market shifts, regulatory complexity, and evolving global health demands.